The Latin America, Middle East and Africa Protein Expression Market would witness market growth of 12.3% CAGR during the forecast period (2022-2028).
The protein expression market is primarily driven by advances in manufacturing techniques, molecular genetics, and inventions like mass spectrometry. The market should also profit from the rapid developments in medical technology, better disease detection, and the growth of the healthcare industry in developing nations. Due to the increased need for personalized therapies and the quickly expanding R&D activities that enable protein expression, the market is anticipated to rise. Protein engineering and the synthetic production of recombinant proteins are the driving forces behind the creation of protein therapies.
Age-related illnesses, a growing geriatric population, and an increase in the incidence of chronic diseases like cancer are some of the factors boosting the protein expression market's growth. The development of protein expression is inducing a rise in interest in protein-related research to aid in drug manufacturing. The formation of DNA to propagate the protein expression is a recent development. This has a huge impact in the overall speed of the expression and the production of results of the tests. This has further aided in the utilization of protein expression in the pharmaceutical industry.
On the use of protein expression technologies in the drug research and development sector, it is projected that pharmaceutical companies' growing interest in investing in protein expression analysis will have a favorable effect. In the upcoming years, Latin America's pharmaceutical industry is anticipated to expand significantly. International pharmaceutical firms with operations in Latin America are putting money into fresh approaches to medication development. Colombia's protein expression industry is driven by continuous efforts undertaken by international sequencing and gene expression companies. These reasons have presented the region with huge growth prospects for the protein expression market.
The Brazil market dominated the LAMEA Protein Expression Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $80.1 Million by 2028. The Argentina market is estimated to witness a CAGR of 12.9% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 12% during (2022 - 2028).
Based on System, the market is segmented into Prokaryotic, Mammalian Cell, Insect Cell, Yeast, and Others. Based on Product, the market is segmented into Reagents, Competent Cells, Instruments, Services, and Others. Based on Application, the market is segmented into Therapeutic, Industrial, Research. Based on End-user, the market is segmented into Pharmaceutical & Biotechnological Companies, Academic Research, Contract Research Organizations, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Protein Expression Market is Predict to reach $4.9 Billion by 2028, at a CAGR of 10.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck Group, New England BioLabs, Inc., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and LGC Biosearch Technologies.
By System
By Product
By Application
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 